Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Could be us soon... OCX up 60%
View:
Post by Nailbiter2 on Mar 16, 2023 3:54pm

Could be us soon... OCX up 60%

May be an image of 2 people, beard, people standing and text
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests.
Comment by Jonnyboy85 on Mar 16, 2023 5:11pm
Good on you for keeping up posting during my little battle of twits with LTstink. While he's constantly professing to posting "oNLy FaCTs"  lolol some people are actually posting them, much appreciated
Comment by LithLover on Mar 16, 2023 5:17pm
Look at the financials for both ocx and stage. OCX annual revenues of $7 million gross profit of 0.19 million and has a market cap of $35 million Stage annual revenues of $5 million gross profit of 1.19 million.  Valued at $11 million market cap.  Based on ocx valuation stage should be $25 million or $0.25 share price.  Very undervalued and once Tripp starts showing revenue ...more  
Comment by Liked2Think on Mar 16, 2023 5:22pm
Agreed 25 cents would be massive. Only 10 cents under what I sold at.  gonna have that $30M in revenue anytime now I can feel it baby!  Yippeee
Comment by Jonnyboy85 on Mar 16, 2023 6:56pm
Hahaha you never owned a single share LieuTenantStink, we're a little past that fairytale at this point don't you think?
Comment by brad129 on Mar 16, 2023 9:42pm
just to put something burried back to top so people have something to read.
Comment by Liked2Think on Mar 16, 2023 11:17pm
look at the chart on it the past 2 years your pumping a stock that has lost even more than Stagezero in that time frame! pathetic!
Comment by Liked2Think on Mar 16, 2023 5:19pm
Super cool nails
Comment by IainCaimbeul on Mar 16, 2023 7:17pm
Nailer: oopsie, ya forgot to mention the OCX stock price on or about 1 Apr 2021 was $5.24 USD; tanked shortly after (maybe they released a flagship product, sigh), so yeah it fits almost exactly with the szls story so far. Dream on.
Comment by Liked2Think on Mar 16, 2023 11:12pm
the pumper patrol likes to leave out history fyi history does not matter!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities